HSK3486 + Propofol
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Sedation and Anesthesia for Adult Colonoscopy Procedures
Conditions
Sedation and Anesthesia for Adult Colonoscopy Procedures
Trial Timeline
Dec 14, 2017 → Aug 9, 2018
NCT ID
NCT03709056About HSK3486 + Propofol
HSK3486 + Propofol is a phase 2 stage product being developed by Haisco Pharmaceutical Group for Sedation and Anesthesia for Adult Colonoscopy Procedures. The current trial status is completed. This product is registered under clinical trial identifier NCT03709056. Target conditions include Sedation and Anesthesia for Adult Colonoscopy Procedures.
What happened to similar drugs?
9 of 20 similar drugs in Sedation and Anesthesia for Adult Colonoscopy Procedures were approved
Approved (9) Terminated (2) Active (11)
✅Remimazolam Tosilate for Injection + Remimazolam Tosilate for InjectionJiangsu Hengrui MedicineApproved
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (11)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04669821 | Phase 2 | Completed |
| NCT04620031 | Phase 3 | Completed |
| NCT04511728 | Phase 3 | Completed |
| NCT04111159 | Phase 3 | Completed |
| NCT03808844 | Phase 3 | Completed |
| NCT03745625 | Phase 1 | Completed |
| NCT03674008 | Phase 3 | Completed |
| NCT03709056 | Phase 2 | Completed |
| NCT03698617 | Phase 2 | Completed |
| NCT03773042 | Phase 2 | Completed |
| NCT04037657 | Phase 1 | Completed |
Competing Products
20 competing products in Sedation and Anesthesia for Adult Colonoscopy Procedures